Drug Shortage Report for MESNA FOR INJECTION
Report ID | 88604 |
Drug Identification Number | 02244931 |
Brand name | MESNA FOR INJECTION |
Common or Proper name | Mesna for Injection |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | MESNA |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS ORAL |
Packaging size | 10mL Vial |
ATC code | V03AF |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-08-26 |
Actual start date | |
Estimated end date | 2019-10-15 |
Actual end date | 2019-09-13 |
Shortage status | Resolved |
Updated date | 2019-09-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-07-05 | English | Compare |
v2 | 2019-07-05 | French | Compare |
v3 | 2019-08-02 | English | Compare |
v4 | 2019-08-02 | English | Compare |
v5 | 2019-08-02 | French | Compare |
v6 | 2019-08-27 | English | Compare |
v7 | 2019-09-13 | English | Compare |
v8 | 2019-09-13 | French | Compare |
v9 | 2019-09-14 | English | Compare |
Showing 1 to 9 of 9